Co-Authors
This is a "connection" page, showing publications co-authored by WAYNE GOODMAN and SANJAY MATHEW.
Connection Strength
0.887
-
Aperiodic (1/f) neural activity robustly tracks symptom severity changes in treatment-resistant depression. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 Nov 13.
Score: 0.062
-
Towards objective, temporally resolved neurobehavioral predictors of emotional state. Brain Stimul. 2024 Nov-Dec; 17(6):1208-1212.
Score: 0.062
-
Efficacy of Deep Brain Stimulation for Treatment-Resistant Depression: Systematic Review and Meta-Analysis. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 Dec; 9(12):1239-1248.
Score: 0.061
-
Intracranial Directed Connectivity Links Subregions of the Prefrontal Cortex to Major Depression. medRxiv. 2024 Aug 08.
Score: 0.061
-
Beta activity in human anterior cingulate cortex mediates reward biases. Nat Commun. 2024 Jul 15; 15(1):5528.
Score: 0.061
-
Insula uses overlapping codes for emotion in self and others. bioRxiv. 2024 Jun 08.
Score: 0.060
-
Stereo-Electroencephalography-Guided Network Neuromodulation for Psychiatric Disorders: The Neurophysiology Monitoring Unit. Oper Neurosurg (Hagerstown). 2024 Sep 01; 27(3):329-336.
Score: 0.059
-
Prefrontal network engagement by deep brain stimulation in limbic hubs. Front Hum Neurosci. 2023; 17:1291315.
Score: 0.059
-
Stereo-EEG-guided network modulation for psychiatric disorders: Surgical considerations. Brain Stimul. 2023 Nov-Dec; 16(6):1792-1798.
Score: 0.058
-
Using latent profile analyses to classify subjects with anhedonia based on reward-related measures obtained in the FAST-MAS study. J Affect Disord. 2023 10 15; 339:584-592.
Score: 0.057
-
Decoding Depression Severity From Intracranial Neural Activity. Biol Psychiatry. 2023 09 15; 94(6):445-453.
Score: 0.055
-
Deep Brain Stimulation for Depression Informed by Intracranial Recordings. Biol Psychiatry. 2022 08 01; 92(3):246-251.
Score: 0.050
-
Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS). Neuropsychopharmacology. 2021 Nov; 46(12):2224.
Score: 0.050
-
Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS). Neuropsychopharmacology. 2020 09; 45(10):1656-1663.
Score: 0.046
-
A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating ?-opioid antagonism as a treatment for anhedonia. Nat Med. 2020 05; 26(5):760-768.
Score: 0.045
-
The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development. Nat Rev Drug Discov. 2018 12 28; 18(1):82-84.
Score: 0.041